Medical Device Manufacturers
Clinical evidence that supports market entry
Validation, clinical safety and market-readiness for device and SaMD makers — with honest regulatory boundaries.
How we help
From evidence to market
Clinical validation
Independent evaluation of performance and safety.
Clinical safety
DCB0129 safety case and hazard log support.
Market readiness
Evidence and procurement preparation.
Boundary. We provide clinical evidence and assurance support. Formal conformity assessment, UKCA marking and registration remain your responsibility, with your regulatory advisers.
The manufacturer's dilemma
A regulatory mark is necessary, but it does not sell the device
Device and software-as-a-medical-device manufacturers invest heavily in achieving regulatory clearance, then find that clearance alone does not unlock NHS sales. Conformity assessment answers the regulator's question — is this device acceptably safe and performing as intended — but the NHS buyer asks a different one: can we deploy this safely into our setting, with evidence that stands up to our clinical-safety and information-governance teams. Manufacturers strong in engineering and regulatory affairs often have less depth in the clinical-deployment evidence and procurement assurance that decides whether a contract actually closes.
The gap is widest for SaMD and AI-enabled devices. A precise intended-use statement, evidence of clinical validity for the claimed use, and a clinical-safety case under DCB0129 are increasingly expected by sophisticated buyers — and getting them wrong, or building them in the wrong order, wastes both money and the credibility of a launch. We sit in the space between your regulatory pathway and the buyer's deployment decision, building the clinical and assurance evidence that turns a cleared device into a procured one.
How an engagement works
From intended use to a buyer-ready evidence pack
- Sharpen the intended use. We help you state precisely what the device claims to do, for whom, and in what setting — the foundation every later piece of evidence has to support.
- Build clinical evidence. Independent clinical validation of performance and safety against that claim, including subgroup considerations for AI-enabled products.
- Support the safety case. Hazard log and DCB0129 manufacturer clinical-safety documentation, prepared alongside your regulatory advisers.
- Ready it for buyers. Procurement and NHS buyer-readiness materials so your sales team meets clinical-safety and IG questions with evidence, not improvisation.
We typically work with heads of clinical, regulatory affairs leads, product owners and commercial teams. Where a device depends on data exchange with NHS systems, our interoperability assessment strengthens the deployment case; where buyers want post-market real-world evidence, our healthcare data analytics capability can support it. We also assist distributors with compliant medical device sourcing for the UK market.
Answers
Frequently asked questions
Do you handle regulatory submissions?
We support clinical evidence, clinical safety (DCB0129 where applicable) and market-readiness. Formal conformity assessment, UKCA marking and notified-body engagement remain with you; we help you prepare and we work alongside your regulatory advisers.
Can you help with software as a medical device (SaMD)?
Yes — including intended-use definition, clinical validation and safety. See AI Validation & Clinical Safety.
Do you support market entry?
We provide clinical evidence and procurement/market-access readiness to support entry into UK and adjacent markets.
Can you help us with NHS procurement once we are CE/UKCA marked?
Yes. A regulatory mark gets you to the starting line; NHS buyers then ask for DTAC alignment, clinical-safety evidence and a DPIA before they will deploy. We help you assemble that buyer-facing pack. See NHS Buyer Readiness.
We are a distributor, not the original manufacturer — can you still help?
Yes. Distributors and UK responsible persons often need to demonstrate clinical evidence and deployment safety to NHS customers even where the underlying conformity assessment sits with the original manufacturer. We can support that buyer-facing assurance and sourcing work.
Bringing a device to market?
We'll help you build the clinical evidence buyers and regulators expect.